Shreya Life Sciences - India
Shreya Life Sciences, the Indian arm of Shreya Group started its operations in India in the year 2001 by acquiring the Pharma Division of Rallis India Ltd., a TATA Group company. In 2003, Shreya acquired the domestic pharma business of Plethico Pharmaceuticals Ltd., with a view to achieve a full-fledged national presence.
Today, Shreya Life Sciences Pvt. Ltd., Mumbai - India, operates through three Strategic Business Units (SBUs).
Sales & Marketing Setup
Shreya's marketing operations are handled through a field force of over 1000 Sales & Marketing Associates who cover more than 200,000 doctors of major speciality segments viz.,
Efforts of the field personnel are backed by a full-fledged support system comprising of:
Sales Management team at Corporate and Regional level
Marketing Management Team at Corporate
Training Department both at the Corporate & in the field
Medical & Regulatory Cell
Shreya has strategic alliance with Bio Technology General Corporation, USA,
through SciGen, Singapore and Scitech USA to import and market Recombinant Human
Insulin, Hepatitis B Vaccine & Growth Hormone (BTGC acquired by Ferring).
License agreement with Bioton, Poland, to import Recombinant Human Insulin Crystals and finished formulation of Recombinant Human Insulin Cartridges through SciGen.
License agreement with Biotech GmBH, Germany (BBT) to market Gonadotropins in India.
License agreement with Generex Biotechnology Corporation, Canada / USA to distribute and market Oral Recosulin, 'Oral-Lyn' on an exclusive basis in Indian sub-continent which includes India, Nepal, Pakistan, Bhutan, Bangladesh, Srilanka & Myanmar .
Licence agreement with Lallemand and Institute Rosell, France, to market Probiotics.
Supply Chain Network
Supply Chain Management at Shreya consists of two main areas of operations viz.
All India Distribution Management
APIs & Excipients from domestic and international markets
Quality Sales Promotional items
The Supply Chain Team is fully qualified & conversant with norms for procurement of APIs and PMs for regulated markets
Distribution Management adopts both an extensive and intensive approach in their reach & penetration strategy & in the process ensures that SHREYA product range is availble at all stock points spread across the country. The distribution team is responsible for effective and quick movement of finished goods from &/or to:
Manufacturing points to the two Central Warehouses located at Indore(MP) & Bhiwandi (Thane) respectively.
Various stock points (C&Fs) located at 23 different cities in India
These 23 C&Fs of SHREYA cater to the needs of over 3000 stockists at District level. Today, Shreya’s products are available with 150,000 retailers across the country.
Supplying till the last level
Physician’s Sample movement from Factory to Medical Representative is independent of commercial goods movement. This is ensured by having a separate Warehouse at Bhiwandi, Dist. Thane, Maharashtra which
Receives Physician’s Samples from the factories
And then distributes separately to Field Force through C&Fs
Cold chain maintenance
There is an effective & well organised/infrastructured cold chain supply management system at Shreya’s Distribution channel with
Walk-in coolers at warehouses. Temperature sensitive products are stored and transported under cold conditions
... right from manufactureing points to thier last destination - viz the customer.